Caris Upgrades Par Pharmaceutical (PRX) to Above Average
Tweet Send to a Friend
Caris & Co. upgrades Par Pharmaceutical (NYSE: PRX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
